Related Experiment Video
Updated: Mar 18, 2026

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Microalbuminuria in Obese Young and Middle Aged Population: A Potential Marker of Cardiovascular Risk
Purvi Purohit1, Kunal Garg2, Vikram Singh3
1Department of Biochemistry, AIIMS Jodhpur, Jodhpur, India.
Abstract:
Microalbuminuria is an established cardiovascular risk indicator in diabetes, hypertension and the general population. There is lack of information on MAU in healthy obese Indian adults and an ongoing debate whether obese adults deserve targeted identification and clinical intervention for MAU and prediabetes. We aimed to screen the healthy obese, young (group I) and middle aged (group II) adults for prevalence of MAU and prediabetes and study its association with Framingham risk score. The study included 50 healthy obese young (20-30 years) and middle aged adults (31-50 years), attending the outpatient clinic of Dept. of Medicine for a duration of 2 months (July-August). The patients were screened for fasting blood sugar, lipid profile and MAU. Of the total patients 28 % had MAU, 32.14 % of which had prediabetes and 33.33 % had diabetes whereas 10 % were normoglycemic. The group I patients had 50 % cases of MAU and group II had 25 % patients with MAU. Group II 63.63 % pre-diabetics. The values of MAU obtained were correlated with age, gender, body mass index, systolic and diastolic blood pressure, FBS, waist to hip ratio using Pearson's Coefficient (p < 0.05). The 10 year CVD risk calculated using FRS in subjects with MAU was higher as compared to those without MAU. Thus we conclude that Indian, young and middle aged obese adults to be at a risk of prediabetes, MAU and CV risk warranting their routine screening for better clinical outcomes.
Insights
Microalbuminuria (MAU) is common in healthy obese Indian adults, indicating increased cardiovascular risk and prediabetes. Routine screening for MAU in this population is recommended for better health outcomes.
Area of Science:
- Endocrinology
- Cardiology
- Nephrology
Background:
- Microalbuminuria (MAU) is a known cardiovascular risk indicator.
- Limited data exists on MAU prevalence in healthy obese Indian adults.
- Debate continues regarding targeted screening for MAU and prediabetes in obese populations.
Purpose of the Study:
- To determine the prevalence of MAU and prediabetes in healthy obese young and middle-aged Indian adults.
- To investigate the association between MAU, prediabetes, and cardiovascular risk using the Framingham Risk Score (FRS).
Main Methods:
- A study involving 50 healthy obese adults (aged 20-50 years) was conducted over two months.
- Screening included fasting blood sugar, lipid profile, and MAU.
- Data was analyzed using Pearson's Correlation and FRS for 10-year CVD risk assessment.
Main Results:
- 28% of participants had MAU, with 32.14% of those having prediabetes and 33.33% having diabetes.
- Younger obese adults (Group I) showed a 50% MAU prevalence, while middle-aged adults (Group II) had 25% MAU and 63.63% prediabetes.
- MAU correlated with age, BMI, blood pressure, and waist-to-hip ratio (p < 0.05).
- Individuals with MAU exhibited a higher 10-year CVD risk based on FRS.
Conclusions:
- Healthy obese Indian adults, both young and middle-aged, are at risk for prediabetes and MAU.
- Elevated MAU is associated with increased cardiovascular risk in this demographic.
- Routine screening for MAU and prediabetes in obese Indian adults is crucial for improved clinical outcomes.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Obesity
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...